Article Versions Notes

Bucșa C, Frenț I, Stefan R, Fodor A, Inceu G, Farcaș A, Rusu A, Negovan M, Mogoșan C. Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study. Pharmaceuticals. 2025; 18(6):904. https://doi.org/10.3390/ph18060904

Bucșa, Camelia, Ioana Frenț, Ramona Stefan, Adriana Fodor, Georgeta Inceu, Andreea Farcaș, Adriana Rusu, Monica Negovan, and Cristina Mogoșan. 2025. "Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study" Pharmaceuticals 18, no. 6: 904. https://doi.org/10.3390/ph18060904

Bucșa, C., Frenț, I., Stefan, R., Fodor, A., Inceu, G., Farcaș, A., Rusu, A., Negovan, M., & Mogoșan, C. (2025). Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study. Pharmaceuticals, 18(6), 904. https://doi.org/10.3390/ph18060904